You have access
First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German Study
ANDREAS SCHNEEWEISS, FRANK FÖRSTER, HANS TESCH, BAHRIYE AKTAS, OLEG GLUZ, MATTHIAS GEBERTH, MARTIN M. HERTZ-EICHENRODE, WINFRIED SCHÖNEGG, CLAUDIA SCHUMACHER, ANDREAS KUTSCHEIDT, CLAUDIA KIEWITZ, SANDRA KLAWITTER and MARCUS SCHMIDT
Anticancer Research March 2016, 36 (3) 967-974;